EA200900602A1 - Применение альфа 1-тимозина для приготовления лекарства для профилактики и лечения аутоиммунных заболеваний - Google Patents

Применение альфа 1-тимозина для приготовления лекарства для профилактики и лечения аутоиммунных заболеваний

Info

Publication number
EA200900602A1
EA200900602A1 EA200900602A EA200900602A EA200900602A1 EA 200900602 A1 EA200900602 A1 EA 200900602A1 EA 200900602 A EA200900602 A EA 200900602A EA 200900602 A EA200900602 A EA 200900602A EA 200900602 A1 EA200900602 A1 EA 200900602A1
Authority
EA
Eurasian Patent Office
Prior art keywords
alpha
preparation
treatment
autoimmune diseases
tymosine
Prior art date
Application number
EA200900602A
Other languages
English (en)
Inventor
Луиджина Романи
Франческо Бистони
Энрико Гарачи
Гуидо Рази
Валлебона Паола Синибалди
Original Assignee
Сигма-Тау Индустрие Фармачеутике Риуните С.П.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сигма-Тау Индустрие Фармачеутике Риуните С.П.А. filed Critical Сигма-Тау Индустрие Фармачеутике Риуните С.П.А.
Publication of EA200900602A1 publication Critical patent/EA200900602A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2292—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Настоящее изобретение касается применения альфа 1-тимозина для приготовления лекарства для профилактики и лечения аутоиммунных заболеваний, таких как рассеянный склероз, и воспалительных заболеваний кишечника, таких как болезнь Крона или неспецифический язвенный колит.
EA200900602A 2006-10-27 2007-09-27 Применение альфа 1-тимозина для приготовления лекарства для профилактики и лечения аутоиммунных заболеваний EA200900602A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000584A ITRM20060584A1 (it) 2006-10-27 2006-10-27 Uso della timosina alfa 1 la preparazione di un medicamento per la prevenzione e la cura delle malattie autoimmuni
PCT/IT2007/000677 WO2008050363A2 (en) 2006-10-27 2007-09-27 Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of autoimmune diseases

Publications (1)

Publication Number Publication Date
EA200900602A1 true EA200900602A1 (ru) 2009-10-30

Family

ID=39322489

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200900602A EA200900602A1 (ru) 2006-10-27 2007-09-27 Применение альфа 1-тимозина для приготовления лекарства для профилактики и лечения аутоиммунных заболеваний

Country Status (13)

Country Link
US (1) US20100004174A1 (ru)
EP (1) EP2086569A2 (ru)
JP (1) JP2010507650A (ru)
KR (1) KR20090096688A (ru)
CN (1) CN101534853A (ru)
AU (1) AU2007310416A1 (ru)
BR (1) BRPI0718010A2 (ru)
CA (1) CA2666609A1 (ru)
EA (1) EA200900602A1 (ru)
IL (1) IL198291A0 (ru)
IT (1) ITRM20060584A1 (ru)
MX (1) MX2009004196A (ru)
WO (1) WO2008050363A2 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100248272A1 (en) * 2009-03-31 2010-09-30 Cornell University Method for identifying Smk box riboswitch modulating compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5852225A (ja) * 1981-09-22 1983-03-28 Mitsui Pharmaceut Inc 脱髄疾患治療剤
US4444757A (en) * 1981-11-16 1984-04-24 Research Corporation Use of thymosin as an anti-diabetes and anti-hypertensive disease agent
TW249754B (ru) * 1993-10-26 1995-06-21 Alpha I Biomedicals Inc
US5888980A (en) * 1994-06-30 1999-03-30 Bio-Logic Research And Development Corporation Compositions for enhancing immune function
CA2270223A1 (en) * 1996-10-28 1998-05-07 Carson B. Burgstiner (Deceased) Methods and compositions for dietary supplementation
CN1198950A (zh) * 1998-04-24 1998-11-18 崔泊 一种结肠炎新药的制备
CN1628796A (zh) * 2004-08-20 2005-06-22 康合堂 一种治疗溃疡性结肠炎的药物

Also Published As

Publication number Publication date
BRPI0718010A2 (pt) 2013-11-19
MX2009004196A (es) 2009-06-30
WO2008050363A3 (en) 2008-06-26
IL198291A0 (en) 2011-08-01
CA2666609A1 (en) 2008-05-02
US20100004174A1 (en) 2010-01-07
WO2008050363A8 (en) 2009-06-04
EP2086569A2 (en) 2009-08-12
KR20090096688A (ko) 2009-09-14
CN101534853A (zh) 2009-09-16
WO2008050363A2 (en) 2008-05-02
ITRM20060584A1 (it) 2008-04-28
JP2010507650A (ja) 2010-03-11
AU2007310416A1 (en) 2008-05-02

Similar Documents

Publication Publication Date Title
ME02414B (me) Tretman kronove bolesti lakvinimodom
WO2009033821A3 (en) Use of a peptide as a therapeutic agent
EA200971130A1 (ru) Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний
WO2009043522A3 (en) Use of a peptide as a therapeutic agent
MA28935B1 (fr) Preparation et utilisation de derives de biphenyl-4-yl-carbonylamino-acide dans le traitement de l'obesite
TN2010000137A1 (en) Spiropyrrolidines and their use against hcv and hiv infection
MX346335B (es) Composiciones antisentido, y metodos para obtener y usar las mismas.
MXPA05007711A (es) Copolimero 1 para el tratamiento de enfermedades inflamatorias del intestino.
EA200600971A1 (ru) Применение замещённых 2 - аминотетралинов для профилактического лечения болезни паркинсона
MA32841B1 (fr) Composés de cycloundeca depsipeptides et leur utilisation comme médicament
NO20023962D0 (no) Bruk av IL-18-inhibitorer
MX2009003301A (es) Novedoso inmunogeno neutralizante (nimiv) de rhinovirus y su uso para aplicaciones de vacunas.
NO20076405L (no) Anvendelse av 24-nor-UDCA
WO2007081486A3 (en) Oral administration of defensins to treat intestinal diseases
TNSN08385A1 (en) Delayed-release glucocorticoid treatment of rheumatoid disease
JO2999B1 (ar) مركب ثلاثي حلقي و استخدامه الدوائي
DE602007007934D1 (en) Imidazoazephinonverbindungen
MX2011011618A (es) Agentes terapeuticos 713.
MA39448B1 (fr) (r)-pirlindole et ses sels pharmaceutiquement acceptables destinés à un usage médical
WO2007121545A8 (en) S-nitrosothiols containing compositions for the treatment of fatty liver diseases, obesity and other diseases associated with the metabolic syndrome and the use of such compositions
EA200900602A1 (ru) Применение альфа 1-тимозина для приготовления лекарства для профилактики и лечения аутоиммунных заболеваний
EA201171229A1 (ru) Терапевтическое применение производных хиназолиндиона при сердечно-сосудистых заболеваниях
WO2009033814A3 (en) Use of the peptide combination thymosin beta 4 and delta sleep inducing peptide as a therapeutic agent
WO2009033816A3 (en) Use of the combination of thymosin beta 10 and thymosin alpha 1 peptides as a therapeutic agent
WO2009046875A3 (en) Combination of splenopentin and thymopentin and the use thereof in medicine